Best Practice & Research Clinical Haematology

Papers
(The H4-Index of Best Practice & Research Clinical Haematology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
HLA typing: A review of methodologies and clinical impact on haematopoietic cell transplantation79
The role of randomized controlled trials, registries, observational databases in evaluating new interventions49
Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes43
Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program38
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALL38
Allogeneic “Off-the-Shelf” CAR T cells: Challenges and advances25
Endpoint selection and evaluation in hematology studies25
Coagulopathy in COVID-19 and anticoagulation clinical trials25
“The state of the science” of childhood, adolescent and young adult Non Hodgkin Lymphoma (NHL)24
Editorial Board23
The presentation of results from studies in clinical haematology23
Take a spin: Apheresis in the care of adult leukaemia patients22
How can we improve response assessments in MDS? Strategies to improve response assessment in MDS treatment paradigms15
Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma15
Creating a GMP cell processing program: A focus on quality and regulation14
Vaccine-induced immune thrombotic thrombocytopenia14
0.30679702758789